Insider Trading Activity For Syneos Health Inc (NASDAQ:SYNH)
Alistair Macdonald , CEO of Syneos Health Inc (NASDAQ:SYNH) reportedly Sold 8,143 shares of the company’s stock at an average price of 53 for a total transaction amount of $431,579.00 SEC Form
Insider Trading History For Syneos Health Inc (NASDAQ:SYNH)
Analyst Ratings History For Syneos Health Inc (NASDAQ:SYNH)
- On 8/7/2017 Goldman Sachs Group Reiterated Rating Buy to Buy with a price target of $65.00
- On 11/10/2017 Jefferies Financial Group Reiterated Rating Buy with a price target of $55.00
- On 1/4/2018 Credit Suisse Group Reiterated Rating Buy with a price target of $52.00
- On 2/23/2018 Wells Fargo & Co Upgraded rating Market Perform to Outperform
- On 4/20/2018 Mitsubishi UFJ Financial Group Initiated Coverage of rating Overweight with a price target of $50.00
- On 8/6/2018 Mizuho Reiterated Rating Hold with a price target of $51.00
- On 8/10/2018 KeyCorp Boost Price Target of rating Overweight to Overweight with a price target of $54.00 to $59.00
Recent Trading Activity for Syneos Health Inc (NASDAQ:SYNH)
Shares of Syneos Health Inc closed the previous trading session at 53.88 up +1.02 1.93% with 51.62 shares trading hands.